Activation of p38 MAPKinase/cPLA2 pathway in homocysteine-treated platelets. - Wikidata - awgldk - TriplyDB

Activation of p38 MAPKinase/cPLA2 pathway in homocysteine-treated platelets.

Activation of p38 MAPKinase/cPLA2 pathway in homocysteine-treated platelets.

http://www.wikidata.org/entity/Q46892248

about

Reconciling the evidence on serum homocysteine and ischaemic heart disease: a meta-analysis Oral administration of cytosolic PLA2 inhibitor arachidonyl trifluoromethyl ketone ameliorates cauda equina compression injury in rats Homocysteine induces cardiomyocyte dysfunction and apoptosis through p38 MAPK-mediated increase in oxidant stress.Effect of homocysteine on calcium mobilization and platelet function in type 2 diabetes mellitus.Cytochrome P450 (CYP) 2J2 gene transfection attenuates MMP-9 via inhibition of NF-kappabeta in hyperhomocysteinemia Cardiac dys-synchronization and arrhythmia in hyperhomocysteinemia.Effect of homocysteine on calcium mobilization and platelet function in type 2 diabetes mellitus.(S)-tetrahydroisoquinoline alkaloid inhibits LPS-induced arachidonic acid release through downregulation of cPLA2 expression.Endothelial dysfunction: the link between homocysteine and hydrogen sulfide.Hydrogen sulfide decreases the plasma lipid peroxidation induced by homocysteine and its thiolactone.Methyl deficient diet aggravates experimental colitis in rats.Homocysteine and its thiolactone may promote apoptotic events in blood platelets in vitro.The polyphenol-rich extracts from black chokeberry and grape seeds impair changes in the platelet adhesion and aggregation induced by a model of hyperhomocysteinemia.Comparative studies on homocysteine and its metabolite-homocysteine thiolactone action in blood platelets in vitro.Role of homocysteine and folic acid on the altered calcium homeostasis of platelets from rats with biliary cirrhosis.

P2860

Q28743107-C072A39E-31AA-4CF2-BE98-EFD4D67970B1 Q34476283-2E700FE5-D74A-4FC3-A7CC-EE737B298159 Q35803548-B04B7E2D-15A2-4228-8855-2B3F668F9F1B Q35862492-7511253D-6F80-4325-A0C7-1B846C4EDC2F Q36625899-EAD7A6E6-E65A-4F34-94A4-9DBE59F23D3D Q37017926-EE656083-64E5-4B99-AE9D-3765F19EA7F5 Q37310670-470F4F02-E5C0-4BB6-AEAF-AF2835F82D4E Q37462486-60F379B1-8A36-4225-B380-7959823083E8 Q38227415-521B91AF-08A2-4A54-A513-5E3BA40B9FE3 Q41379098-C5DB297A-C38A-4CA0-B5DB-C05F4382F9FC Q41969373-BC9C4D23-54E8-4473-830E-DD67BB89A35E Q42940610-CA033829-6E15-49E0-AEAD-69E1C8129EBC Q45420752-EB6C8632-F5BA-4C64-895C-C781122D250E Q46268344-7E5AEAD2-EA51-4E42-AA59-6E89A192430C Q46424366-14A9F83F-936D-4BC6-9CD2-98A43063962F

P2860

Activation of p38 MAPKinase/cPLA2 pathway in homocysteine-treated platelets.

http://www.wikidata.org/entity/Q46892248

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Activation of p38 MAPKinase/cPLA2 pathway in homocysteine-treated platelets.

@en

Activation of p38 MAPKinase/cPLA2 pathway in homocysteine-treated platelets.

@nl

type

label

Activation of p38 MAPKinase/cPLA2 pathway in homocysteine-treated platelets.

@en

Activation of p38 MAPKinase/cPLA2 pathway in homocysteine-treated platelets.

@nl

prefLabel

Activation of p38 MAPKinase/cPLA2 pathway in homocysteine-treated platelets.

@en

Activation of p38 MAPKinase/cPLA2 pathway in homocysteine-treated platelets.

@nl

P1433

Q46892248-6812BBD9-BD66-4430-8793-345301E6F441

P1476

Q46892248-4A6D9CCC-899A-44C6-8D15-9568B60E7292

P2093

Q46892248-610A175F-6FC4-41C5-B926-D38B0F11D11E

Q46892248-737A3949-F9DB-43FA-BAA8-F4FD1C69B5A9

Q46892248-F2DC25B0-8C2E-40D7-B92A-4DDCBAA22318

P2860

Q46892248-00A1AE4C-6A76-40B6-802D-55C5E76C0C99

Q46892248-0920F3C6-E6EA-49C0-A8C6-BE2ADC68096B

Q46892248-0CEC0FCD-11EB-4AF2-BE76-92643B5AE651

Q46892248-2033619C-D37E-44B3-914A-D266300B6696

Q46892248-23B47E95-A8FF-46E6-998C-5BA9B98E254C

Q46892248-24367586-D786-4012-A9CD-90C5E117C2D8

Q46892248-3F140C36-6C0E-47D1-9B80-53ECF8A1E069

Q46892248-41A32614-7E8A-4045-BABD-C5A62D4FD926

Q46892248-441219DA-47EB-4E24-9F1B-FE02F617A289

Q46892248-503B27F1-1692-4E1C-9BBB-DA5B9D496F4A

P304

Q46892248-4A7FD826-3A40-4ADC-878F-5CD41B64488C

P31

Q46892248-05AA2F7B-42E5-42B6-A6DA-6ABE942F46F5

P356

Q46892248-CAFA99B0-45DA-4145-BE93-93AAD18F89B6

P433

Q46892248-2A81026C-B73C-45C7-B46F-2002C45A9899

P478

Q46892248-AED6E08E-D9A4-4A56-B055-7164F2A90F9D

P577

Q46892248-50AE2176-025F-4D06-BC8B-976A20B2CD30

P5875

Q46892248-1477100F-BE7F-4296-8DC3-E257ED991E4C

P698

Q46892248-2EBDB74E-DE44-455D-A58B-93BE12F74292

P356

J.1538-7836.2005.01708.X

P1433

Journal of Thrombosis and Haemostasis

P1476

Activation of p38 MAPKinase/cPLA2 pathway in homocysteine-treated platelets.

@en

P2093

D Bruzzese

http://www.w3.org/2001/XMLSchema#string

G Leoncini

http://www.w3.org/2001/XMLSchema#string

M G Signorello

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structure of a calcium-phospholipid binding domain from cytosolic phospholipase A2

Identification of the phosphorylation sites of cytosolic phospholipase A2 in agonist-stimulated human platelets and HeLa cells

A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP

N-acetylcysteine attenuates TNF-alpha-induced p38 MAP kinase activation and p38 MAP kinase-mediated IL-8 production by human pulmonary vascular endothelial cells

p38 mitogen-activated protein kinase phosphorylates cytosolic phospholipase A2 (cPLA2) in thrombin-stimulated platelets. Evidence that proline-directed phosphorylation is not required for mobilization of arachidonic acid by cPLA2

Cytosolic phospholipase A2 is coupled to hormonally regulated release of arachidonic acid

Redox regulatory mechanisms of cellular signal transduction.

Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism

Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine

Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia.

P304

209-216

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1538-7836.2005.01708.X

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7363661

http://www.w3.org/2001/XMLSchema#string

P698

16409471

http://www.w3.org/2001/XMLSchema#string